Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Sheba Medical Center |
---|---|
Information provided by: | Sheba Medical Center |
ClinicalTrials.gov Identifier: | NCT00818727 |
SSRI treatment in adults was found to decrease bone density. The use of SSRI among pregnant women with depression or anxiety is extendent and raising.
The effect of bone density of the infants was not yet evaluated.
Condition |
---|
Bone Density |
Study Type: | Observational |
Study Design: | Case Control, Prospective |
Estimated Enrollment: | 40 |
Study Start Date: | February 2009 |
Estimated Primary Completion Date: | January 2011 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | up to 7 Days |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Healthy term newborn infants to mothers treated with SSRI and healthy controls. bone density mesurment will be applied on the 1-7 days of life.
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | sheba medical center ( Dr.Ayala Maayan ) |
Study ID Numbers: | SHEBA-09-5435-AM-CTIL |
Study First Received: | January 7, 2009 |
Last Updated: | January 7, 2009 |
ClinicalTrials.gov Identifier: | NCT00818727 History of Changes |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
Bone density SSRI newborn infants |
Neurotransmitter Agents Serotonin Uptake Inhibitors Serotonin |
Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Serotonin Agents Molecular Mechanisms of Pharmacological Action |
Physiological Effects of Drugs Serotonin Uptake Inhibitors Pharmacologic Actions |